BioNeutral Group, Inc. Answering President Obama’s Call to Clean Fossil Burning Emissions and Greenhouse Gasses

NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (OTCBB: BONU), a specialty life science company with a unique combinational chemistry-based technology, reports its proprietary Ogiene™ formulation can entrap and deliver the active chemical environment necessary to eliminate a variety of noxious and toxic gases which harm the planet and threaten all who occupy it. “This is a multi billion dollar opportunity and the impact will be extremely positive for countless industries across our country,” said Dr. Andy Kielbania, Ph.D., Chief Scientist at BioNeutral Group, Inc. “You can clearly see the results of our Ogiene™ formulation in a toxic smoke-filled fire situation illustrated in this field test video.” <See Video>

“You can clearly see the results of our Ogiene™ formulation in a toxic smoke-filled fire situation illustrated in this field test video.”

Elimination of Toxic Gases and Irritants with Ogiene™
Gas	Threshold Smell	Levels in Test	% Reduced in 10 seconds	% Reduced in 1 minute
H2S (Hydrogen sulfide)	2ppb	20-50ppm	50	95
NH3 (Ammonia)	17ppm	20-50ppm	25	80
SO2 (Sulfur dioxide)	3ppm	50-150ppm	99	100
CO2 (Carbon dioxide)	Na	2000ppm	10	25
Formaldehyde	0.8ppm	17-41ppm	80	99
Acetic Acid	0.4ppm	17-25ppm	20	60
ppm= parts per million; ppb = parts per billion

Dr. Vasu Kulkarni, Ph.D., who specializes in Chemical and Environmental engineering and is a member of the Scientific Advisory Board said, “While more studies will be required, Ogiene™ technology may very well prove to be one of the most important control technologies available to address toxic and hazardous gases and it may extend its reach to address the precursor gases that contribute to the generation of greenhouse gas emissions.”

Ogiene™ is rapid acting and effective on a wide variety of gases. It is non-toxic and usually requires minimal or no cleanup after application. Ogiene™ is effective in the gas phase being applied as a fog and in the liquid phase, it can be applied as a mist or spray directly to liquid contaminates. Ogiene™ products can be used as barrier curtains, in an exhaust stream (smoke stack) or in confined static spaces and amenable to a variety of methods of application.

“This is a technology (Ogiene™) which answers the call of President Obama for inventiveness and innovation which will help power the country and address the serious environmental issues that we all face,” said President and CEO of BioNeutral Group, Inc., Stephen J. Browand. “This technology can help reduce the air pollution produced by the manufacturing process, create new jobs and continue to make the country more competitive and “Green” to the environment.”

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a novel combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene™ and Ogiene™, which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral’s proprietary platform technology has been proven effective in surface, water and airborne applications.

More information about the Company may be found at www.bioneutralgroup.com

The video of the field test illustrating Ogiene™ smoke suppression may be found at: http://www.bioneutrallabs.vipdigitalsolutions.com/images/burn_video.swf

Forward-Looking Statements

BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of BioNeutral Group can be found in the filings of BioNeutral Group with the U.S. Securities and Exchange Commission.